ASCOT trial pinpoints most efficient level of blood thinning treatment for hospitalized COVID-19 patients


The COVID-19 global pandemic remains a major public health challenge. ASCOT researchers aim to discover which treatments are most effective in patients hospitalized with COVID-19.

Alcohol-involved injuries linked to increased risk of dying in the next year

Previous article

A-HIPI decision model can predict survival in adults with advanced-stage Hodgkin lymphoma

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News